 |
Extracorporeal Life Support Organization |
|
|
|
|
Extracorporeal Life Support Organization |
|
|
|
|
About ELSO
|
The Extracorporeal Life Support Organization (ELSO) is an international consortium of health care professionals and scientists who are dedicated to the development and evaluation of novel therapies for support of failing organ systems. Crucial is the promotion of a broad multidisciplinary collaboration. The primary mission of the Organization is to maintain a registry of, at least, use of extracorporeal membrane oxygenation in active ELSO centers. As appropriate, registries of other novel forms of organ system support are within the purview of ELSO. Registry data is to be used to support clinical research, support regulatory agencies, and support individual ELSO centers. ELSO provides educational programs for active centers as well as for the broader medical and lay communities.
Extracorporeal membrane oxygenation (ECMO) for H1N1 Flu
ECMO has been used successfully for flu patients who are failing on optimal treatment. The ECMO survival reported in H1N1 patients has been 50-80%. The estimate of potential cases in the U.S. for the anticipated winter 2009 epidemic is 600-800. Severe pulmonary failure with septic shock is the typical indication for ECMO. On the H1N1web site, ELSO provides a central source for information, finding ECMO referral centers, tracking cases, guidelines for management, and training and education materials.
|
